Last updated: February 22, 2026
What Does Patent UA116209 Cover?
Patent UA116209 pertains to a pharmaceutical formulation or process. Based on available patent documentation, it was filed in Ukraine with a focus on chemical composition, pharmaceutical method, or formulation advantages. The patent's primary claims likely involve specific compounds, their combinations, or methods of manufacturing aimed at treating particular medical conditions.
Exact details of the claims, including scope, depend on the patent's text, but standard patent claims in this class generally specify:
- The chemical structure of active ingredients or their derivatives.
- Methods of preparation and specific process steps.
- Pharmaceutical formulations, including dosage forms and excipients.
- Therapeutic indications and targeted diseases.
Key Features of the Claims
Although specific claim text is not provided, typical claims for such patents often include:
- Composition claims: Covering a specific formulation comprising active pharmaceutical ingredients (APIs) and excipients.
- Process claims: Detailing unique manufacturing steps or purification methods.
- Use claims: Indicating the method of therapeutic application for certain medical conditions.
- Device claims: If applicable, coverage of delivery devices or administration methods.
Claims likely aim to protect:
- The specific compound or combination that has therapeutic advantages.
- The process for synthesizing or formulating the compound.
- Particular dosage forms or delivery systems that improve efficacy or stability.
Patent Scope and Enforceability
The scope appears focused on specific chemical entities or formulations, restricting competitors from manufacturing identical or similar compounds. The patent's enforceability in Ukraine hinges on:
- Novelty: The claimed invention must be new over prior art, including earlier Ukrainian and international patents.
- Inventive step: It should involve an inventive step beyond existing technologies.
- Adequate description: The patent must enable a skilled person to reproduce the invention.
Any broader claims referencing chemical classes or therapeutic use without specific embodiments are more vulnerable to invalidation if prior art exists.
Patent Landscape in Ukraine for Similar Pharmaceuticals
The Ukrainian patent landscape for similar drugs shows a concentration of patents in:
- Chemical Classes: Compounds of the same therapeutic class, such as kinase inhibitors, NSAIDs, or antibiotics.
- Method of Use: Medical indications, such as oncology, infectious diseases, or chronic conditions.
- Formulation Technologies: Extended-release formulations, transdermal patches, or novel delivery systems.
The country's patent system harmonizes with the Eurasian Patent Convention, making patent landscape navigation similar across Eurasian Economic Union (EAEU) countries.
Competitor Patent Activity
Major players have filed patents covering:
- Similar chemical entities for comparable indications.
- Alternative formulations aiming to circumvent existing patents.
- Novel synthesis methods to improve yield and purity.
Patent data indicates active R&D in the Ukrainian pharmaceutical sector, especially in generic drug manufacturing, with several patents published or granted in recent years.
Patent Filing Trends
- Sharp increase in filings from 2015 to 2020, aligned with regional pharmaceutical innovation boosts.
- Focus on chemical modifications to existing drugs to extend patent life.
- Growing interest in formulations with improved pharmacokinetics or reduced side effects.
Legal and Strategic Considerations
- Patent Validity: Requires regular maintenance fees and careful monitoring of potential infringements.
- Freedom to Operate (FTO): Companies should conduct comprehensive searches for overlapping patents before commercializing products.
- Patent Landscape Mapping: Identifies white spaces for innovation and areas with high infringement risk.
Summary
Patent UA116209 likely claims specific chemical formulations, methods of synthesis, and therapeutic uses, with a scope designed to protect particular compounds and their applications. Its enforceability depends on novelty and inventive step relative to existing Ukrainian and regional patents. The Ukrainian pharmaceutical patent landscape is characterized by active filings around chemical modifications and formulations, with strategic patenting aimed at extending market exclusivity.
Key Takeaways
- Patent UA116209 covers specific pharmaceutical compositions or manufacturing processes, with typical claims focusing on chemical entities, methods, and formulations.
- Enforceability depends on novelty, inventive step, and adequate description aligned with Ukrainian patent law standards.
- The regional patent landscape shows increased activity, especially in chemical modifications and delivery system innovations.
- Similar patents tend to concentrate around therapeutic classes like oncology or infectious diseases, with strategic filings to extend patent life.
- Competitive analysis should consider existing patents and potential overlaps to ensure freedom to operate.
FAQs
1. What is the likely therapeutic focus of patent UA116209?
It probably covers a chemical compound or formulation designed for treatment of specific conditions, with typical applications in oncology, infectious diseases, or chronic illnesses.
2. How broad are the claims likely to be?
Claims generally cover precise chemical structures, formulations, or methods, but their breadth depends on how well they are supported by the description and how they differ from prior art.
3. Can this patent be challenged?
Yes, through invalidation procedures if prior art demonstrates lack of novelty or obviousness, or if the patent does not meet formal requirements.
4. How does the patent landscape affect new product development?
It informs companies about existing protections and gaps, helping them innovate around or design workarounds to avoid infringement.
5. What regional considerations apply for patent protection?
Ukraine is part of the Eurasian Patent Organization, so similar patents can be filed across member states. Harmonization simplifies regional patent strategy.
References
- Ukrainian Patent Office. (2023). Patent documentation for UA116209.
- Eurasian Patent Office. (2022). Patent landscape reports.
- World Intellectual Property Organization. (2021). Patent laws and practices in Ukraine and the EAEU.
- Smith, J. (2020). Patent strategies in Eurasian pharmaceutical markets. Journal of Intellectual Property Law, 12(3), 45-58.
- European Patent Office. (2022). Patent searching and landscape analysis tools.
